INTRODUCTION

40
Sickle cell disease (SCD) is an inherited monogenic inherited anemia with variable 41 clinical manifestation and associated disease severity (1) since some patients present with severe 42 complications, while others do not present with any of SCD complications (2) Besides 43 vasoocclusive crisis (VOC), osteomyelitis is a common complication of SCD, and is a major 44 cause for hospitalization of SCD patients (3) It can present as acute or a chronic inflammatory 45 destruction of the bone, and is characterized by progressive destruction of infected bone and 46 recruitment of osteocytes to the infection sites, which include femur, humerus, vertebra, ribs, 47 (14; 23.7%), and femur (7; 11.9%) were the main sites of infection. Treatment of osteomyelitis 86 consisted of intravenous penicillin and a cephalosporin, used either alone or in combination. 87
Control patients included afebrile SCD patients with no history of SCD-associated bone 88 involvement, and were matched with osteomyelitis patients according to gender, hemoglobin 89 profile (HbS, HbF), and other hematological indices (Table 1) . Local research and ethics 90 committees approved the study protocol, which was in agreement with the Helsinki declaration 91 of 2000. All participants (or guardians in the pediatric cases) gave written informed consent, 92 after the purpose of the study was explained to them. 93 94 Serum IL-10 Measurement. Peripheral venous blood was collected from osteomyelitis SCD 95 cases during active osteomyelitis episodes, and from steady-state SCD controls into plain tubes 96 (no anticoagulants). Serum was prepared by centrifugation of coagulated peripheral venous 97 blood at 2000g for 10 min at 4°C, and was stored in aliquots at or below -30°C. Samples were 98 tested for IL-10 using human IL-10 sandwich enzyme-linked immunosorbent assay (ELISA; 99 R&D Systems, Minneapolis, MN). Assay sensitivity was 3.9 pg/ml, and inter-assay and intra-100 assay precision (CV%) ranged from 5.9-7.5% and 1.7-5.0%, respectively. 101 operating characteristic (ROC) curves. Scatter plot analyses were initially used to present the 108 distribution of IL-10 among groups of individuals, with values out of percentiles 5-95 interval 109
shown as individual points. The osteomyelitis risk was estimated in osteomyelitis patients 110 relative to control SCD patients by calculating the odds ratios (OR) and 95% confidence interval 111 (CI), according to the method of Woolf. IL-10 values were compared using comparison of 112 quartiles technique to detect systematic switch of values toward one of the two groups. OR and 113 95%CI were also calculated for different cutoff points, based on the distribution in control 114 subjects; IL-10 levels were used as continuous and then as categorized variables. 115
116
RESULTS
117
The demographic and clinical characteristics of the study participants are shown in Table  118 1. The Osteomyelitis group consisted of 52 SCD patients with confirmed diagnosis of 119 osteomyelitis, while the control group consisted of 165 age (P = 0.118) and gender-matched (P = 120 0.268) SCD subjects with a negative history of osteomyelitis. With the exception of platelet 121 count (P = 0.039), all biochemical and hematological indices were comparable between the two 122 SCD patient groups. Mean IL-10 serum value in osteomyelitis SCD patients was 15.9 ± 6.4 123 pg/ml, which was significantly lower than that of control SCD individuals of 27.2 ± 17.8 pg/ml 124 (P <0.001). In addition, there was no association between the nature of the bacterial infection 125 (salmonella vs. staphylococcus) and serum IL-10 levels (P = 0.254). 126
Receiver operating characteristic (ROC) analysis was performed in order to determine the 127 predictive value of IL-10 levels in the prediction of osteomyelitis (Fig. 1) . Area-under-ROC 128 curves provided good discriminatory power for IL-10 and osteomyelitis, and demonstrated that 129 on January 27, 2018 by guest http://cvi.asm.org/ Downloaded from reduced IL-10 with osteomyelitis (Table 3) . None of the variables entered in the model (HbS, 152
HbF, platelet and WBC count) were found to be associated with osteomyelitis (Table 3) . 
